Evidence map›Paper›PMID 37999612›Full record

ArticleTropical medicine and infectious disease2023

Using Regional Sero-Epidemiology SARS-CoV-2 Anti-S Antibodies in the Dominican Republic to Inform Targeted Public Health Response.

Beatris Mario Martin, Angela Cadavid Restrepo, Helen J Mayfield, Cecilia Then Paulino, Micheal De St Aubin, William Duke, Petr Jarolim, Emily Zielinski Gutiérrez, Ronald Skewes Ramm, Devan Dumas and 12 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 4 countries.

Beatris Mario MartinSchool of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4006, Australia.ORCID 0000-0002-8264-0153
Angela Cadavid RestrepoSchool of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4006, Australia.
Helen J MayfieldSchool of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4006, Australia.ORCID 0000-0003-3462-4324
Cecilia Then PaulinoMinistry of Health and Social Assistance, Santo Domingo 10514, Dominican Republic.
Micheal De St AubinBrigham and Women's Hospital, Boston, MA 02115, USA.
William DukeFaculty of Health Sciences, Pedro Henriquez Urena National University, Santo Domingo 10514, Dominican Republic.
Petr JarolimBrigham and Women's Hospital, Boston, MA 02115, USA.
Emily Zielinski GutiérrezCenters for Disease Control and Prevention, Central America Regional Office, Guatemala City 01015, Guatemala.
Ronald Skewes RammMinistry of Health and Social Assistance, Santo Domingo 10514, Dominican Republic.
Devan DumasBrigham and Women's Hospital, Boston, MA 02115, USA.
Salome GarnierBrigham and Women's Hospital, Boston, MA 02115, USA.ORCID 0000-0003-3802-115X
Marie Caroline EtienneBrigham and Women's Hospital, Boston, MA 02115, USA.
Farah PeñaMinistry of Health and Social Assistance, Santo Domingo 10514, Dominican Republic.ORCID 0000-0001-7308-6552
Gabriela AbdallaBrigham and Women's Hospital, Boston, MA 02115, USA.
Beatriz LopezCenters for Disease Control and Prevention, Central America Regional Office, Guatemala City 01015, Guatemala.ORCID 0000-0003-1353-9948
Lucia de la CruzMinistry of Health and Social Assistance, Santo Domingo 10514, Dominican Republic.
Bernarda HenríquezMinistry of Health and Social Assistance, Santo Domingo 10514, Dominican Republic.
Margaret BaldwinBrigham and Women's Hospital, Boston, MA 02115, USA.
Benn SartoriusSchool of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4006, Australia.
Adam KucharskiDepartment of Infectious Disease Epidemiology and Dynamics, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
Eric James NillesBrigham and Women's Hospital, Boston, MA 02115, USA.ORCID 0000-0001-7044-5257
Colleen L LauSchool of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4006, Australia.ORCID 0000-0001-8288-4169
Brigham and Women's Hospital · USThe University of Queensland · AULondon School of Hygiene & Tropical Medicine · GBUniversidad Nacional Pedro Henríquez Ureña · DO

Funding

CGH CDC HHS U01 GH002238
6 · The paper itself

Abstract

Incidence of COVID-19 has been associated with sociodemographic factors. We investigated variations in SARS-CoV-2 seroprevalence at sub-national levels in the Dominican Republic and assessed potential factors influencing variation in regional-level seroprevalence. Data were collected in a three-stage cross-sectional national serosurvey from June to October 2021. Seroprevalence of antibodies against the SARS-CoV-2 spike protein (anti-S) was estimated and adjusted for selection probability, age, and sex. Multilevel logistic regression was used to estimate the effect of covariates on seropositivity for anti-S and correlates of 80% protection (PT

Indexed as

SARS-CoV-2seroprevalencespatial distributionvaccine

Identifiers

PMID37999612
PMCPMC10675152
OpenAlexW4388331688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.